Recursion Pharmaceuticals (RXRX)
(Real Time Quote from BATS)
$8.93 USD
-0.23 (-2.51%)
Updated May 28, 2024 12:46 PM ET
3-Hold of 5 3
F Value F Growth A Momentum F VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
08/13/2024
Time: -- |
6/2024 | $-0.41 | 0.00% |
Earnings Summary
For their last quarter, Recursion Pharmaceuticals (RXRX) reported earnings of -$0.39 per share, beating the Zacks Consensus Estimate of $-0.43 per share. This reflects a positive earnings surprise of 9.30%. Look out for RXRX's next earnings release expected on August 13, 2024. For the next earning release, we expect the company to report earnings of -$0.41 per share, reflecting a year-over-year decrease of 7.89%.
Earnings History
Price & Consensus
Zacks News for RXRX
Recursion Pharmaceuticals (RXRX) Reports Q1 Loss, Tops Revenue Estimates
RXRX: What are Zacks experts saying now?
Zacks Private Portfolio Services